Endocrinology · Bartlett, TN
NPI
1902913692
Since 2006
Specialty
Endocrinology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3025 Kate Bond Rd
Bartlett, TN, 38133
Phone (901) 384-0065
Groups this clinician bills Medicare through
Medicare paid, 2024
$692K
33,134 services
Medicare patients, 2024
1,253
Average age 73
Drug cost, 2024
$6.2M
14,494 prescriptions
Company payments, 2025
$117K
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kashif A Latif was code 99490 (chronic, principal, and transitional care management), 3,186 times for 568 patients. In total Kashif A Latif billed 33,134 services in 120 codes, and Medicare paid $692K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 3,186 | 568 | $41.06 | $131K |
| 36415 Venipuncture Blood Collection | Office | 2,312 | 1,071 | $8.58 | $20K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 1,900 | 18 | $0.10 | $184 |
| 84439 Clinical Chemistry | Office | 1,829 | 1,000 | $8.73 | $16K |
| 80053 Clinical Chemistry | Office | 1,811 | 994 | $10.32 | $19K |
| 84443 Clinical Chemistry | Office | 1,804 | 983 | $16.39 | $30K |
| 85025 Blood Count | Office | 1,792 | 986 | $7.60 | $14K |
| 99214 Office E&M - Established | Office | 1,775 | 936 | $82.64 | $147K |
| 80061 Clinical Chemistry | Office | 1,534 | 888 | $12.98 | $20K |
| 83036 Blood Count | Office | 1,466 | 806 | $9.40 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,462 | 786 | $11.28 | $16K |
| 82306 Clinical Chemistry | Office | 1,087 | 765 | $28.62 | $31K |
| 84480 Clinical Chemistry | Office | 724 | 468 | $13.77 | $9,972 |
| 95251 Test - Miscellaneous | Office | 710 | 344 | $24.01 | $17K |
| 83735 Clinical Chemistry | Office | 608 | 393 | $6.51 | $3,959 |
By year: 2022 $570K for 27,192 services; 2023 $714K for 31,433 services; 2024 $692K for 33,134 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 2,312 | 1,071 | $8.58 | $20K |
| 84439 Clinical Chemistry | 1,829 | 1,000 | $8.73 | $16K |
| 80053 Clinical Chemistry | 1,811 | 994 | $10.32 | $19K |
| 84443 Clinical Chemistry | 1,804 | 983 | $16.39 | $30K |
| 85025 Blood Count | 1,792 | 986 | $7.60 | $14K |
| 80061 Clinical Chemistry | 1,534 | 888 | $12.98 | $20K |
| 83036 Blood Count | 1,466 | 806 | $9.40 | $14K |
| 82306 Clinical Chemistry | 1,087 | 765 | $28.62 | $31K |
| 84480 Clinical Chemistry | 724 | 468 | $13.77 | $9,972 |
| 83735 Clinical Chemistry | 608 | 393 | $6.51 | $3,959 |
Medicare prescription drug claims, 2024
In 2024, the drug Kashif A Latif prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,123 prescriptions and refills. In total Kashif A Latif wrote 14,494 Medicare prescriptions that cost $6.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,123 | 3,072 | 347 | $12K |
| Ozempic Semaglutide | 1,004 | 1,565 | 246 | $1.4M |
| Mounjaro Tirzepatide | 663 | 922 | 168 | $949K |
| Metformin Hcl Generic | 502 | 1,425 | 174 | $3,699 |
| Jardiance Empagliflozin | 487 | 1,050 | 164 | $576K |
| Tresiba Flextouch U-100 Insulin Degludec | 430 | 905 | 148 | $309K |
| Atorvastatin Calcium Generic | 387 | 1,102 | 146 | $3,823 |
| Rosuvastatin Calcium Generic | 372 | 1,095 | 153 | $4,988 |
| Amlodipine Besylate Generic | 349 | 1,010 | 131 | $2,444 |
| Losartan Potassium Generic | 345 | 968 | 133 | $3,557 |
| Farxiga Dapagliflozin Propanediol | 331 | 670 | 103 | $348K |
| Synthroid Levothyroxine Sodium | 274 | 632 | 70 | $22K |
| Trulicity Dulaglutide | 272 | 472 | 81 | $457K |
| Metformin Hcl Er Metformin Hcl | 270 | 773 | 100 | $2,924 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 269 | 531 | 90 | $38K |
Brand drugs: 6,709 claims; generic drugs: 6,951 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kashif A Latif $117K ($116K in general payments such as food, travel and fees and $1,555 for research) from 33 companies. The largest payer was Sanofi-Aventis U.S. LLC with $88K.
| Company | Payments | Amount |
|---|---|---|
| Sanofi-Aventis U.S. LLC SNY | 45 | $88K |
| Mannkind Corporation MNKD | 9 | $13K |
| Genzyme Corporation SNY | 1 | $8,320 |
| Insulet Corporation PODD | 22 | $2,319 |
| Lilly USA, LLC LLY | 12 | $1,572 |
| Sanofi US Services Inc. SNY | 11 | $1,555 |
| Novo Nordisk Inc NVO | 22 | $393 |
| Abbvie Inc. ABBV | 23 | $288 |
| Xeris Pharmaceuticals, Inc. | 13 | $240 |
| IBSA Pharma Inc. | 4 | $234 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.